Global TCR-Based Antibody Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
TCr-Based Antibodies are used in treatment of cancer, lymphoma, myeloma, etc., these antibodies directly attack on the target and kills them.
According to our (Global Info Research) latest study, the global TCR-Based Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global TCR-Based Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global TCR-Based Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global TCR-Based Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global TCR-Based Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global TCR-Based Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for TCR-Based Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global TCR-Based Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics and Lion TCR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
TCR-Based Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe TCR-Based Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TCR-Based Antibody, with price, sales, revenue and global market share of TCR-Based Antibody from 2018 to 2023.
Chapter 3, the TCR-Based Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TCR-Based Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and TCR-Based Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of TCR-Based Antibody.
Chapter 14 and 15, to describe TCR-Based Antibody sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global TCR-Based Antibody market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global TCR-Based Antibody market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global TCR-Based Antibody market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global TCR-Based Antibody market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global TCR-Based Antibody market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global TCR-Based Antibody market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for TCR-Based Antibody
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global TCR-Based Antibody market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptimmune Therapeutics, Celgene, Immunocore, Kuur Therapeutics and Lion TCR, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
TCR-Based Antibody market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- NY-ESO-1
- p53
- WT-1
- EBv
- Others
- Hospitals
- Specialized Clinics
- Pharma and Biotech Research Laboratories.
- Gene Therapy Centers
- Others
- Adaptimmune Therapeutics
- Celgene
- Immunocore
- Kuur Therapeutics
- Lion TCR
- Kite Pharma
- Takara Bio
- Ziopharm Oncology
- GlaxoSmithKline
- Merck
- Juno Theraprutics
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe TCR-Based Antibody product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of TCR-Based Antibody, with price, sales, revenue and global market share of TCR-Based Antibody from 2018 to 2023.
Chapter 3, the TCR-Based Antibody competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TCR-Based Antibody breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and TCR-Based Antibody market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of TCR-Based Antibody.
Chapter 14 and 15, to describe TCR-Based Antibody sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of TCR-Based Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global TCR-Based Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 NY-ESO-1
1.3.3 p53
1.3.4 WT-1
1.3.5 EBv
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global TCR-Based Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialized Clinics
1.4.4 Pharma and Biotech Research Laboratories.
1.4.5 Gene Therapy Centers
1.4.6 Others
1.5 Global TCR-Based Antibody Market Size & Forecast
1.5.1 Global TCR-Based Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global TCR-Based Antibody Sales Quantity (2018-2029)
1.5.3 Global TCR-Based Antibody Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Adaptimmune Therapeutics
2.1.1 Adaptimmune Therapeutics Details
2.1.2 Adaptimmune Therapeutics Major Business
2.1.3 Adaptimmune Therapeutics TCR-Based Antibody Product and Services
2.1.4 Adaptimmune Therapeutics TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Adaptimmune Therapeutics Recent Developments/Updates
2.2 Celgene
2.2.1 Celgene Details
2.2.2 Celgene Major Business
2.2.3 Celgene TCR-Based Antibody Product and Services
2.2.4 Celgene TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Celgene Recent Developments/Updates
2.3 Immunocore
2.3.1 Immunocore Details
2.3.2 Immunocore Major Business
2.3.3 Immunocore TCR-Based Antibody Product and Services
2.3.4 Immunocore TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Immunocore Recent Developments/Updates
2.4 Kuur Therapeutics
2.4.1 Kuur Therapeutics Details
2.4.2 Kuur Therapeutics Major Business
2.4.3 Kuur Therapeutics TCR-Based Antibody Product and Services
2.4.4 Kuur Therapeutics TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kuur Therapeutics Recent Developments/Updates
2.5 Lion TCR
2.5.1 Lion TCR Details
2.5.2 Lion TCR Major Business
2.5.3 Lion TCR TCR-Based Antibody Product and Services
2.5.4 Lion TCR TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lion TCR Recent Developments/Updates
2.6 Kite Pharma
2.6.1 Kite Pharma Details
2.6.2 Kite Pharma Major Business
2.6.3 Kite Pharma TCR-Based Antibody Product and Services
2.6.4 Kite Pharma TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kite Pharma Recent Developments/Updates
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio TCR-Based Antibody Product and Services
2.7.4 Takara Bio TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takara Bio Recent Developments/Updates
2.8 Ziopharm Oncology
2.8.1 Ziopharm Oncology Details
2.8.2 Ziopharm Oncology Major Business
2.8.3 Ziopharm Oncology TCR-Based Antibody Product and Services
2.8.4 Ziopharm Oncology TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ziopharm Oncology Recent Developments/Updates
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline TCR-Based Antibody Product and Services
2.9.4 GlaxoSmithKline TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GlaxoSmithKline Recent Developments/Updates
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck TCR-Based Antibody Product and Services
2.10.4 Merck TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments/Updates
2.11 Juno Theraprutics
2.11.1 Juno Theraprutics Details
2.11.2 Juno Theraprutics Major Business
2.11.3 Juno Theraprutics TCR-Based Antibody Product and Services
2.11.4 Juno Theraprutics TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Juno Theraprutics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TCR-BASED ANTIBODY BY MANUFACTURER
3.1 Global TCR-Based Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global TCR-Based Antibody Revenue by Manufacturer (2018-2023)
3.3 Global TCR-Based Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of TCR-Based Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 TCR-Based Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 TCR-Based Antibody Manufacturer Market Share in 2022
3.5 TCR-Based Antibody Market: Overall Company Footprint Analysis
3.5.1 TCR-Based Antibody Market: Region Footprint
3.5.2 TCR-Based Antibody Market: Company Product Type Footprint
3.5.3 TCR-Based Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global TCR-Based Antibody Market Size by Region
4.1.1 Global TCR-Based Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global TCR-Based Antibody Consumption Value by Region (2018-2029)
4.1.3 Global TCR-Based Antibody Average Price by Region (2018-2029)
4.2 North America TCR-Based Antibody Consumption Value (2018-2029)
4.3 Europe TCR-Based Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific TCR-Based Antibody Consumption Value (2018-2029)
4.5 South America TCR-Based Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa TCR-Based Antibody Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global TCR-Based Antibody Sales Quantity by Type (2018-2029)
5.2 Global TCR-Based Antibody Consumption Value by Type (2018-2029)
5.3 Global TCR-Based Antibody Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global TCR-Based Antibody Sales Quantity by Application (2018-2029)
6.2 Global TCR-Based Antibody Consumption Value by Application (2018-2029)
6.3 Global TCR-Based Antibody Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America TCR-Based Antibody Sales Quantity by Type (2018-2029)
7.2 North America TCR-Based Antibody Sales Quantity by Application (2018-2029)
7.3 North America TCR-Based Antibody Market Size by Country
7.3.1 North America TCR-Based Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America TCR-Based Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe TCR-Based Antibody Sales Quantity by Type (2018-2029)
8.2 Europe TCR-Based Antibody Sales Quantity by Application (2018-2029)
8.3 Europe TCR-Based Antibody Market Size by Country
8.3.1 Europe TCR-Based Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe TCR-Based Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific TCR-Based Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific TCR-Based Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific TCR-Based Antibody Market Size by Region
9.3.1 Asia-Pacific TCR-Based Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific TCR-Based Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America TCR-Based Antibody Sales Quantity by Type (2018-2029)
10.2 South America TCR-Based Antibody Sales Quantity by Application (2018-2029)
10.3 South America TCR-Based Antibody Market Size by Country
10.3.1 South America TCR-Based Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America TCR-Based Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa TCR-Based Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa TCR-Based Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa TCR-Based Antibody Market Size by Country
11.3.1 Middle East & Africa TCR-Based Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa TCR-Based Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 TCR-Based Antibody Market Drivers
12.2 TCR-Based Antibody Market Restraints
12.3 TCR-Based Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of TCR-Based Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of TCR-Based Antibody
13.3 TCR-Based Antibody Production Process
13.4 TCR-Based Antibody Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 TCR-Based Antibody Typical Distributors
14.3 TCR-Based Antibody Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of TCR-Based Antibody
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global TCR-Based Antibody Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 NY-ESO-1
1.3.3 p53
1.3.4 WT-1
1.3.5 EBv
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global TCR-Based Antibody Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Specialized Clinics
1.4.4 Pharma and Biotech Research Laboratories.
1.4.5 Gene Therapy Centers
1.4.6 Others
1.5 Global TCR-Based Antibody Market Size & Forecast
1.5.1 Global TCR-Based Antibody Consumption Value (2018 & 2022 & 2029)
1.5.2 Global TCR-Based Antibody Sales Quantity (2018-2029)
1.5.3 Global TCR-Based Antibody Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Adaptimmune Therapeutics
2.1.1 Adaptimmune Therapeutics Details
2.1.2 Adaptimmune Therapeutics Major Business
2.1.3 Adaptimmune Therapeutics TCR-Based Antibody Product and Services
2.1.4 Adaptimmune Therapeutics TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Adaptimmune Therapeutics Recent Developments/Updates
2.2 Celgene
2.2.1 Celgene Details
2.2.2 Celgene Major Business
2.2.3 Celgene TCR-Based Antibody Product and Services
2.2.4 Celgene TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Celgene Recent Developments/Updates
2.3 Immunocore
2.3.1 Immunocore Details
2.3.2 Immunocore Major Business
2.3.3 Immunocore TCR-Based Antibody Product and Services
2.3.4 Immunocore TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Immunocore Recent Developments/Updates
2.4 Kuur Therapeutics
2.4.1 Kuur Therapeutics Details
2.4.2 Kuur Therapeutics Major Business
2.4.3 Kuur Therapeutics TCR-Based Antibody Product and Services
2.4.4 Kuur Therapeutics TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Kuur Therapeutics Recent Developments/Updates
2.5 Lion TCR
2.5.1 Lion TCR Details
2.5.2 Lion TCR Major Business
2.5.3 Lion TCR TCR-Based Antibody Product and Services
2.5.4 Lion TCR TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lion TCR Recent Developments/Updates
2.6 Kite Pharma
2.6.1 Kite Pharma Details
2.6.2 Kite Pharma Major Business
2.6.3 Kite Pharma TCR-Based Antibody Product and Services
2.6.4 Kite Pharma TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kite Pharma Recent Developments/Updates
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio TCR-Based Antibody Product and Services
2.7.4 Takara Bio TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Takara Bio Recent Developments/Updates
2.8 Ziopharm Oncology
2.8.1 Ziopharm Oncology Details
2.8.2 Ziopharm Oncology Major Business
2.8.3 Ziopharm Oncology TCR-Based Antibody Product and Services
2.8.4 Ziopharm Oncology TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ziopharm Oncology Recent Developments/Updates
2.9 GlaxoSmithKline
2.9.1 GlaxoSmithKline Details
2.9.2 GlaxoSmithKline Major Business
2.9.3 GlaxoSmithKline TCR-Based Antibody Product and Services
2.9.4 GlaxoSmithKline TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 GlaxoSmithKline Recent Developments/Updates
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business
2.10.3 Merck TCR-Based Antibody Product and Services
2.10.4 Merck TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merck Recent Developments/Updates
2.11 Juno Theraprutics
2.11.1 Juno Theraprutics Details
2.11.2 Juno Theraprutics Major Business
2.11.3 Juno Theraprutics TCR-Based Antibody Product and Services
2.11.4 Juno Theraprutics TCR-Based Antibody Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Juno Theraprutics Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: TCR-BASED ANTIBODY BY MANUFACTURER
3.1 Global TCR-Based Antibody Sales Quantity by Manufacturer (2018-2023)
3.2 Global TCR-Based Antibody Revenue by Manufacturer (2018-2023)
3.3 Global TCR-Based Antibody Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of TCR-Based Antibody by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 TCR-Based Antibody Manufacturer Market Share in 2022
3.4.2 Top 6 TCR-Based Antibody Manufacturer Market Share in 2022
3.5 TCR-Based Antibody Market: Overall Company Footprint Analysis
3.5.1 TCR-Based Antibody Market: Region Footprint
3.5.2 TCR-Based Antibody Market: Company Product Type Footprint
3.5.3 TCR-Based Antibody Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global TCR-Based Antibody Market Size by Region
4.1.1 Global TCR-Based Antibody Sales Quantity by Region (2018-2029)
4.1.2 Global TCR-Based Antibody Consumption Value by Region (2018-2029)
4.1.3 Global TCR-Based Antibody Average Price by Region (2018-2029)
4.2 North America TCR-Based Antibody Consumption Value (2018-2029)
4.3 Europe TCR-Based Antibody Consumption Value (2018-2029)
4.4 Asia-Pacific TCR-Based Antibody Consumption Value (2018-2029)
4.5 South America TCR-Based Antibody Consumption Value (2018-2029)
4.6 Middle East and Africa TCR-Based Antibody Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global TCR-Based Antibody Sales Quantity by Type (2018-2029)
5.2 Global TCR-Based Antibody Consumption Value by Type (2018-2029)
5.3 Global TCR-Based Antibody Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global TCR-Based Antibody Sales Quantity by Application (2018-2029)
6.2 Global TCR-Based Antibody Consumption Value by Application (2018-2029)
6.3 Global TCR-Based Antibody Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America TCR-Based Antibody Sales Quantity by Type (2018-2029)
7.2 North America TCR-Based Antibody Sales Quantity by Application (2018-2029)
7.3 North America TCR-Based Antibody Market Size by Country
7.3.1 North America TCR-Based Antibody Sales Quantity by Country (2018-2029)
7.3.2 North America TCR-Based Antibody Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe TCR-Based Antibody Sales Quantity by Type (2018-2029)
8.2 Europe TCR-Based Antibody Sales Quantity by Application (2018-2029)
8.3 Europe TCR-Based Antibody Market Size by Country
8.3.1 Europe TCR-Based Antibody Sales Quantity by Country (2018-2029)
8.3.2 Europe TCR-Based Antibody Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific TCR-Based Antibody Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific TCR-Based Antibody Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific TCR-Based Antibody Market Size by Region
9.3.1 Asia-Pacific TCR-Based Antibody Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific TCR-Based Antibody Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America TCR-Based Antibody Sales Quantity by Type (2018-2029)
10.2 South America TCR-Based Antibody Sales Quantity by Application (2018-2029)
10.3 South America TCR-Based Antibody Market Size by Country
10.3.1 South America TCR-Based Antibody Sales Quantity by Country (2018-2029)
10.3.2 South America TCR-Based Antibody Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa TCR-Based Antibody Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa TCR-Based Antibody Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa TCR-Based Antibody Market Size by Country
11.3.1 Middle East & Africa TCR-Based Antibody Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa TCR-Based Antibody Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 TCR-Based Antibody Market Drivers
12.2 TCR-Based Antibody Market Restraints
12.3 TCR-Based Antibody Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of TCR-Based Antibody and Key Manufacturers
13.2 Manufacturing Costs Percentage of TCR-Based Antibody
13.3 TCR-Based Antibody Production Process
13.4 TCR-Based Antibody Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 TCR-Based Antibody Typical Distributors
14.3 TCR-Based Antibody Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global TCR-Based Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global TCR-Based Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Adaptimmune Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Adaptimmune Therapeutics Major Business
Table 5. Adaptimmune Therapeutics TCR-Based Antibody Product and Services
Table 6. Adaptimmune Therapeutics TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Adaptimmune Therapeutics Recent Developments/Updates
Table 8. Celgene Basic Information, Manufacturing Base and Competitors
Table 9. Celgene Major Business
Table 10. Celgene TCR-Based Antibody Product and Services
Table 11. Celgene TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Celgene Recent Developments/Updates
Table 13. Immunocore Basic Information, Manufacturing Base and Competitors
Table 14. Immunocore Major Business
Table 15. Immunocore TCR-Based Antibody Product and Services
Table 16. Immunocore TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Immunocore Recent Developments/Updates
Table 18. Kuur Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Kuur Therapeutics Major Business
Table 20. Kuur Therapeutics TCR-Based Antibody Product and Services
Table 21. Kuur Therapeutics TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Kuur Therapeutics Recent Developments/Updates
Table 23. Lion TCR Basic Information, Manufacturing Base and Competitors
Table 24. Lion TCR Major Business
Table 25. Lion TCR TCR-Based Antibody Product and Services
Table 26. Lion TCR TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lion TCR Recent Developments/Updates
Table 28. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Kite Pharma Major Business
Table 30. Kite Pharma TCR-Based Antibody Product and Services
Table 31. Kite Pharma TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kite Pharma Recent Developments/Updates
Table 33. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 34. Takara Bio Major Business
Table 35. Takara Bio TCR-Based Antibody Product and Services
Table 36. Takara Bio TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Takara Bio Recent Developments/Updates
Table 38. Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table 39. Ziopharm Oncology Major Business
Table 40. Ziopharm Oncology TCR-Based Antibody Product and Services
Table 41. Ziopharm Oncology TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ziopharm Oncology Recent Developments/Updates
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline TCR-Based Antibody Product and Services
Table 46. GlaxoSmithKline TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GlaxoSmithKline Recent Developments/Updates
Table 48. Merck Basic Information, Manufacturing Base and Competitors
Table 49. Merck Major Business
Table 50. Merck TCR-Based Antibody Product and Services
Table 51. Merck TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck Recent Developments/Updates
Table 53. Juno Theraprutics Basic Information, Manufacturing Base and Competitors
Table 54. Juno Theraprutics Major Business
Table 55. Juno Theraprutics TCR-Based Antibody Product and Services
Table 56. Juno Theraprutics TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Juno Theraprutics Recent Developments/Updates
Table 58. Global TCR-Based Antibody Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global TCR-Based Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global TCR-Based Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in TCR-Based Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and TCR-Based Antibody Production Site of Key Manufacturer
Table 63. TCR-Based Antibody Market: Company Product Type Footprint
Table 64. TCR-Based Antibody Market: Company Product Application Footprint
Table 65. TCR-Based Antibody New Market Entrants and Barriers to Market Entry
Table 66. TCR-Based Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global TCR-Based Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global TCR-Based Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global TCR-Based Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global TCR-Based Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global TCR-Based Antibody Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global TCR-Based Antibody Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global TCR-Based Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global TCR-Based Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global TCR-Based Antibody Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global TCR-Based Antibody Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global TCR-Based Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global TCR-Based Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global TCR-Based Antibody Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global TCR-Based Antibody Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America TCR-Based Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America TCR-Based Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America TCR-Based Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America TCR-Based Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe TCR-Based Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe TCR-Based Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe TCR-Based Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe TCR-Based Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific TCR-Based Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific TCR-Based Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific TCR-Based Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific TCR-Based Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America TCR-Based Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America TCR-Based Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America TCR-Based Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America TCR-Based Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa TCR-Based Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa TCR-Based Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa TCR-Based Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa TCR-Based Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 125. TCR-Based Antibody Raw Material
Table 126. Key Manufacturers of TCR-Based Antibody Raw Materials
Table 127. TCR-Based Antibody Typical Distributors
Table 128. TCR-Based Antibody Typical Customers
Table 1. Global TCR-Based Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global TCR-Based Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Adaptimmune Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Adaptimmune Therapeutics Major Business
Table 5. Adaptimmune Therapeutics TCR-Based Antibody Product and Services
Table 6. Adaptimmune Therapeutics TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Adaptimmune Therapeutics Recent Developments/Updates
Table 8. Celgene Basic Information, Manufacturing Base and Competitors
Table 9. Celgene Major Business
Table 10. Celgene TCR-Based Antibody Product and Services
Table 11. Celgene TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Celgene Recent Developments/Updates
Table 13. Immunocore Basic Information, Manufacturing Base and Competitors
Table 14. Immunocore Major Business
Table 15. Immunocore TCR-Based Antibody Product and Services
Table 16. Immunocore TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Immunocore Recent Developments/Updates
Table 18. Kuur Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. Kuur Therapeutics Major Business
Table 20. Kuur Therapeutics TCR-Based Antibody Product and Services
Table 21. Kuur Therapeutics TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Kuur Therapeutics Recent Developments/Updates
Table 23. Lion TCR Basic Information, Manufacturing Base and Competitors
Table 24. Lion TCR Major Business
Table 25. Lion TCR TCR-Based Antibody Product and Services
Table 26. Lion TCR TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lion TCR Recent Developments/Updates
Table 28. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Kite Pharma Major Business
Table 30. Kite Pharma TCR-Based Antibody Product and Services
Table 31. Kite Pharma TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kite Pharma Recent Developments/Updates
Table 33. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 34. Takara Bio Major Business
Table 35. Takara Bio TCR-Based Antibody Product and Services
Table 36. Takara Bio TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Takara Bio Recent Developments/Updates
Table 38. Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table 39. Ziopharm Oncology Major Business
Table 40. Ziopharm Oncology TCR-Based Antibody Product and Services
Table 41. Ziopharm Oncology TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Ziopharm Oncology Recent Developments/Updates
Table 43. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Major Business
Table 45. GlaxoSmithKline TCR-Based Antibody Product and Services
Table 46. GlaxoSmithKline TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. GlaxoSmithKline Recent Developments/Updates
Table 48. Merck Basic Information, Manufacturing Base and Competitors
Table 49. Merck Major Business
Table 50. Merck TCR-Based Antibody Product and Services
Table 51. Merck TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Merck Recent Developments/Updates
Table 53. Juno Theraprutics Basic Information, Manufacturing Base and Competitors
Table 54. Juno Theraprutics Major Business
Table 55. Juno Theraprutics TCR-Based Antibody Product and Services
Table 56. Juno Theraprutics TCR-Based Antibody Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Juno Theraprutics Recent Developments/Updates
Table 58. Global TCR-Based Antibody Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 59. Global TCR-Based Antibody Revenue by Manufacturer (2018-2023) & (USD Million)
Table 60. Global TCR-Based Antibody Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 61. Market Position of Manufacturers in TCR-Based Antibody, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 62. Head Office and TCR-Based Antibody Production Site of Key Manufacturer
Table 63. TCR-Based Antibody Market: Company Product Type Footprint
Table 64. TCR-Based Antibody Market: Company Product Application Footprint
Table 65. TCR-Based Antibody New Market Entrants and Barriers to Market Entry
Table 66. TCR-Based Antibody Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global TCR-Based Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 68. Global TCR-Based Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 69. Global TCR-Based Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 70. Global TCR-Based Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 71. Global TCR-Based Antibody Average Price by Region (2018-2023) & (US$/Unit)
Table 72. Global TCR-Based Antibody Average Price by Region (2024-2029) & (US$/Unit)
Table 73. Global TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Global TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Global TCR-Based Antibody Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Global TCR-Based Antibody Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Global TCR-Based Antibody Average Price by Type (2018-2023) & (US$/Unit)
Table 78. Global TCR-Based Antibody Average Price by Type (2024-2029) & (US$/Unit)
Table 79. Global TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 80. Global TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 81. Global TCR-Based Antibody Consumption Value by Application (2018-2023) & (USD Million)
Table 82. Global TCR-Based Antibody Consumption Value by Application (2024-2029) & (USD Million)
Table 83. Global TCR-Based Antibody Average Price by Application (2018-2023) & (US$/Unit)
Table 84. Global TCR-Based Antibody Average Price by Application (2024-2029) & (US$/Unit)
Table 85. North America TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 86. North America TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 87. North America TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 88. North America TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 89. North America TCR-Based Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 90. North America TCR-Based Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 91. North America TCR-Based Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 92. North America TCR-Based Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Europe TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 94. Europe TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 95. Europe TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 96. Europe TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 97. Europe TCR-Based Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 98. Europe TCR-Based Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 99. Europe TCR-Based Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe TCR-Based Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 102. Asia-Pacific TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 103. Asia-Pacific TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 104. Asia-Pacific TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 105. Asia-Pacific TCR-Based Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 106. Asia-Pacific TCR-Based Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 107. Asia-Pacific TCR-Based Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 108. Asia-Pacific TCR-Based Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 109. South America TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 110. South America TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 111. South America TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 112. South America TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 113. South America TCR-Based Antibody Sales Quantity by Country (2018-2023) & (K Units)
Table 114. South America TCR-Based Antibody Sales Quantity by Country (2024-2029) & (K Units)
Table 115. South America TCR-Based Antibody Consumption Value by Country (2018-2023) & (USD Million)
Table 116. South America TCR-Based Antibody Consumption Value by Country (2024-2029) & (USD Million)
Table 117. Middle East & Africa TCR-Based Antibody Sales Quantity by Type (2018-2023) & (K Units)
Table 118. Middle East & Africa TCR-Based Antibody Sales Quantity by Type (2024-2029) & (K Units)
Table 119. Middle East & Africa TCR-Based Antibody Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Middle East & Africa TCR-Based Antibody Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Middle East & Africa TCR-Based Antibody Sales Quantity by Region (2018-2023) & (K Units)
Table 122. Middle East & Africa TCR-Based Antibody Sales Quantity by Region (2024-2029) & (K Units)
Table 123. Middle East & Africa TCR-Based Antibody Consumption Value by Region (2018-2023) & (USD Million)
Table 124. Middle East & Africa TCR-Based Antibody Consumption Value by Region (2024-2029) & (USD Million)
Table 125. TCR-Based Antibody Raw Material
Table 126. Key Manufacturers of TCR-Based Antibody Raw Materials
Table 127. TCR-Based Antibody Typical Distributors
Table 128. TCR-Based Antibody Typical Customers
LIST OF FIGURES
Figure 1. TCR-Based Antibody Picture
Figure 2. Global TCR-Based Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global TCR-Based Antibody Consumption Value Market Share by Type in 2022
Figure 4. NY-ESO-1 Examples
Figure 5. p53 Examples
Figure 6. WT-1 Examples
Figure 7. EBv Examples
Figure 8. Others Examples
Figure 9. Global TCR-Based Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global TCR-Based Antibody Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Specialized Clinics Examples
Figure 13. Pharma and Biotech Research Laboratories. Examples
Figure 14. Gene Therapy Centers Examples
Figure 15. Others Examples
Figure 16. Global TCR-Based Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global TCR-Based Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global TCR-Based Antibody Sales Quantity (2018-2029) & (K Units)
Figure 19. Global TCR-Based Antibody Average Price (2018-2029) & (US$/Unit)
Figure 20. Global TCR-Based Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global TCR-Based Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of TCR-Based Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 TCR-Based Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 TCR-Based Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global TCR-Based Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global TCR-Based Antibody Consumption Value Market Share by Region (2018-2029)
Figure 27. North America TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. South America TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 32. Global TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global TCR-Based Antibody Consumption Value Market Share by Type (2018-2029)
Figure 34. Global TCR-Based Antibody Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global TCR-Based Antibody Consumption Value Market Share by Application (2018-2029)
Figure 37. Global TCR-Based Antibody Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America TCR-Based Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America TCR-Based Antibody Consumption Value Market Share by Country (2018-2029)
Figure 42. United States TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe TCR-Based Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe TCR-Based Antibody Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific TCR-Based Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific TCR-Based Antibody Consumption Value Market Share by Region (2018-2029)
Figure 58. China TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America TCR-Based Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America TCR-Based Antibody Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa TCR-Based Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa TCR-Based Antibody Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. TCR-Based Antibody Market Drivers
Figure 79. TCR-Based Antibody Market Restraints
Figure 80. TCR-Based Antibody Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of TCR-Based Antibody in 2022
Figure 83. Manufacturing Process Analysis of TCR-Based Antibody
Figure 84. TCR-Based Antibody Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. TCR-Based Antibody Picture
Figure 2. Global TCR-Based Antibody Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global TCR-Based Antibody Consumption Value Market Share by Type in 2022
Figure 4. NY-ESO-1 Examples
Figure 5. p53 Examples
Figure 6. WT-1 Examples
Figure 7. EBv Examples
Figure 8. Others Examples
Figure 9. Global TCR-Based Antibody Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global TCR-Based Antibody Consumption Value Market Share by Application in 2022
Figure 11. Hospitals Examples
Figure 12. Specialized Clinics Examples
Figure 13. Pharma and Biotech Research Laboratories. Examples
Figure 14. Gene Therapy Centers Examples
Figure 15. Others Examples
Figure 16. Global TCR-Based Antibody Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global TCR-Based Antibody Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global TCR-Based Antibody Sales Quantity (2018-2029) & (K Units)
Figure 19. Global TCR-Based Antibody Average Price (2018-2029) & (US$/Unit)
Figure 20. Global TCR-Based Antibody Sales Quantity Market Share by Manufacturer in 2022
Figure 21. Global TCR-Based Antibody Consumption Value Market Share by Manufacturer in 2022
Figure 22. Producer Shipments of TCR-Based Antibody by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 23. Top 3 TCR-Based Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 24. Top 6 TCR-Based Antibody Manufacturer (Consumption Value) Market Share in 2022
Figure 25. Global TCR-Based Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 26. Global TCR-Based Antibody Consumption Value Market Share by Region (2018-2029)
Figure 27. North America TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 28. Europe TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 29. Asia-Pacific TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 30. South America TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 31. Middle East & Africa TCR-Based Antibody Consumption Value (2018-2029) & (USD Million)
Figure 32. Global TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 33. Global TCR-Based Antibody Consumption Value Market Share by Type (2018-2029)
Figure 34. Global TCR-Based Antibody Average Price by Type (2018-2029) & (US$/Unit)
Figure 35. Global TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 36. Global TCR-Based Antibody Consumption Value Market Share by Application (2018-2029)
Figure 37. Global TCR-Based Antibody Average Price by Application (2018-2029) & (US$/Unit)
Figure 38. North America TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 39. North America TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 40. North America TCR-Based Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 41. North America TCR-Based Antibody Consumption Value Market Share by Country (2018-2029)
Figure 42. United States TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Canada TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. Mexico TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. Europe TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 46. Europe TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 47. Europe TCR-Based Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 48. Europe TCR-Based Antibody Consumption Value Market Share by Country (2018-2029)
Figure 49. Germany TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. France TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. United Kingdom TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Russia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Italy TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Asia-Pacific TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 55. Asia-Pacific TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 56. Asia-Pacific TCR-Based Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 57. Asia-Pacific TCR-Based Antibody Consumption Value Market Share by Region (2018-2029)
Figure 58. China TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Japan TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Korea TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. India TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. Southeast Asia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Australia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. South America TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 65. South America TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 66. South America TCR-Based Antibody Sales Quantity Market Share by Country (2018-2029)
Figure 67. South America TCR-Based Antibody Consumption Value Market Share by Country (2018-2029)
Figure 68. Brazil TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Argentina TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Middle East & Africa TCR-Based Antibody Sales Quantity Market Share by Type (2018-2029)
Figure 71. Middle East & Africa TCR-Based Antibody Sales Quantity Market Share by Application (2018-2029)
Figure 72. Middle East & Africa TCR-Based Antibody Sales Quantity Market Share by Region (2018-2029)
Figure 73. Middle East & Africa TCR-Based Antibody Consumption Value Market Share by Region (2018-2029)
Figure 74. Turkey TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Egypt TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Saudi Arabia TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 77. South Africa TCR-Based Antibody Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 78. TCR-Based Antibody Market Drivers
Figure 79. TCR-Based Antibody Market Restraints
Figure 80. TCR-Based Antibody Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of TCR-Based Antibody in 2022
Figure 83. Manufacturing Process Analysis of TCR-Based Antibody
Figure 84. TCR-Based Antibody Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
